Optimizing Treatment Effects on OSA-related Clinical and Patient-centered Outcomes Among Blacks
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Insomnia Sleep Studies, Pulmonary |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 3/8/2019 |
| Start Date: | September 2019 |
| End Date: | December 2019 |
| Contact: | Lloyd Gyamfi |
| Email: | Lloyd.Gyamfi@nyumc.org |
| Phone: | 646 501 2613 |
The study is to maximize efficacy of message delivery to achieve desired Obstructive sleep
apnea (OSA) adherence goal. Newly diagnosed black patients (n=390, all genders) from
participating sleep clinics will be randomly exposed to either the individually tailored or
standard OSA messages. Investigators will look at an effective and scalable intervention to
improve OSA-related outcomes: a) clinical CVD and brain health measures and b)
patient-centered outcomes. Patient-centered and adherence data will be captured via REDCap,
enabling real-time application of data-driven decision rules while implementing the
intervention.
apnea (OSA) adherence goal. Newly diagnosed black patients (n=390, all genders) from
participating sleep clinics will be randomly exposed to either the individually tailored or
standard OSA messages. Investigators will look at an effective and scalable intervention to
improve OSA-related outcomes: a) clinical CVD and brain health measures and b)
patient-centered outcomes. Patient-centered and adherence data will be captured via REDCap,
enabling real-time application of data-driven decision rules while implementing the
intervention.
Inclusion Criteria:
- Self-reported race/ethnicity as African American, African, Caribbean or black
- Accessible by phone
- No plans to move away within the year
- OSA diagnosis, consent, including permission to release medical data
- Physician-diagnosed medical conditions.
Exclusion Criteria:
- Progressive illnesses in which disability or death is expected within 1 year
- Impaired cognitive/ functional ability precluding participation
- Intention to move within the same year of enrollment
- Family member currently enrolled
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Girardin Jean-Louis, PhD
Phone: 646-501-2613
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
